Alex Schwartz
Stock Analyst at Stifel
(1.84)
# 2,541
Out of 4,667 analysts
11
Total ratings
25%
Success rate
9.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Initiates: Buy | $50 | $21.17 | +136.18% | 4 | Feb 21, 2024 | |
| VTVT vTv Therapeutics | Downgrades: Hold | n/a | $14.83 | - | 2 | Apr 10, 2018 | |
| GERN Geron | Maintains: Hold | $2.5 → $4 | $4.02 | -0.50% | 1 | Mar 19, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $85 → $95 | $2.90 | +3,175.86% | 4 | Mar 9, 2018 |
AnaptysBio
Feb 21, 2024
Initiates: Buy
Price Target: $50
Current: $21.17
Upside: +136.18%
vTv Therapeutics
Apr 10, 2018
Downgrades: Hold
Price Target: n/a
Current: $14.83
Upside: -
Geron
Mar 19, 2018
Maintains: Hold
Price Target: $2.5 → $4
Current: $4.02
Upside: -0.50%
Puma Biotechnology
Mar 9, 2018
Maintains: Buy
Price Target: $85 → $95
Current: $2.90
Upside: +3,175.86%